Cite
HARVARD Citation
Sinn, M. et al. (2020). CONKO-006: A randomised double-blinded phase IIb-study of additive therapy with gemcitabine + sorafenib/placebo in patients with R1 resection of pancreatic cancer – Final results. European journal of cancer. pp. 172-181. [Online].